{"mainPropery":{"diseaseId":10543,"diseaseName":"Duodenal carcinoid syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10543/duodenal-carcinoid-syndrome","synonyms":["NPDC syndrome","Neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome"],"synonyms-with-source":[{"name":"NPDC syndrome"},{"name":"Neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome","source":""}],"identifiers":[{"identifierType":"OMIM","identifierId":"162240"},{"identifierType":"UMLS","identifierId":"C1834232"}]},"diseaseCategories":[{"diseaseTypeId":28,"diseaseTypeName":"Hereditary Cancer Syndromes"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/162240' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=162240' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Duodenal carcinoid syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1590,"resourceId":2202,"resourceName":"Neurofibromatoses and RASopathies: Their Management, Diagnosis, Current and Future Therapeutic Avenues","descriptionText":"<a href='http://ras-pathway-syndromes.com/content/neurofibromatoses-and-rasopathies' target='_blank'>Neurofibromatoses and RASopathies: Their Management, Diagnosis, Current and Future Therapeutic Avenues</a> &lt;br /&gt;\r\nMonday, September 30, 2013 - Tuesday, October 01, 2013 &lt;br /&gt;\r\n&lt;strong&gt;Location:&lt;/strong&gt; Radisson Blu Hotel, Cardiff, Wales &lt;br /&gt;\r\n&lt;strong&gt;Description:&lt;/strong&gt; This international meeting will provide a most comprehensive and up to date account of recent developments in this field. Internationally recognized experts from the UK, Europe and the USA will speak on neurofibromatoses and rasopathies. This meeting will be suitable for medical geneticists, oncologists, dermatologists, neurologists, endocrinologists, psychiatrists, molecular and cellular biologists, genetic counsellors and general practitioners.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:162240' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10420,"relatedDiseaseName":"Neurofibromatosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":1906,"phenoTypeName":"Carcinoid tumor","percentRanges":"-"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","percentRanges":"-"},{"phenoTypeId":9337,"phenoTypeName":"Neurofibromas","percentRanges":"-"},{"phenoTypeId":13292,"phenoTypeName":"Pheochromocytoma","percentRanges":"-"}],"medicalProducts":[{"productId":665,"genericName":"Telotristat etiprate","tradeName":"Xermelo","tradeLink":"http://www.xermelo.com/","manufacturer":"","sponsor":"Lexicon Pharmaceuticals, Inc","indication":"Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/xermelo","medlinePlusLink":""}],"EncodedName":"Duodenal_carcinoid_syndrome"}